Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France)

C Thumerelle, A Deschildre, C Bouquillon, C Santos, A Sardet, M Scalbert, L Delbecque, P Debray, A Dewilde, D Turck, F Leclerc, C Thumerelle, A Deschildre, C Bouquillon, C Santos, A Sardet, M Scalbert, L Delbecque, P Debray, A Dewilde, D Turck, F Leclerc

Abstract

We studied the role of viruses and atypical bacteria in children hospitalized with exacerbated asthma by a prospective study of children with acute asthma admitted to the Department of Pediatrics in Lille, and to 15 hospitals in the Nord-Pas de Calais region, from October 1, 1998-June 30, 1999. We included children aged 2-16 years with active asthma, defined as three or more recurrent episodes of reversible wheezing. The severity of asthma and of asthmatic exacerbations was recorded. Immunofluorescence assays (IFA) on nasopharyngeal secretions (NPS), serological tests, or both, were used for detection of influenza virus, respiratory syncytial virus (RSV), adenovirus, parainfluenza virus, and coronavirus. Polymerase chain reaction (PCR) assays on NPS were used for rhinovirus and enterovirus. Serological tests for Chlamydia pneumoniae and Mycoplasma pneumoniae were performed. A control group of asymptomatic asthmatic outpatients was examined for respiratory viruses (using IFA and PCR). Eighty-two symptomatic children (mean age, 7.9 years) were examined. Viruses were detected in 38% (enterovirus, 15.8%; rhinovirus, 12%; RSV, 7.3%). Serological tests for atypical bacteria were positive in 10% of patients (C. pneumoniae, 5%; M. pneumoniae, 5%). Among the 27 control subjects (mean age, 7.9 years), one PCR was positive for enterovirus. There was no correlation between severity of chronic asthma or asthmatic exacerbations and the diagnosis of infection. Atypical bacterial pathogen infections were linked with prolonged asthmatic symptoms. In conclusion, we confirmed the high incidence of viral infection in acute exacerbations of asthma, especially enteroviruses or rhinoviruses. Persistent clinical features were more frequently associated with atypical bacterial infections, suggesting that these infections should be investigated and treated in cases of persistent asthmatic symptoms.

Copyright 2003 Wiley-Liss, Inc.

References

    1. Pin I, Pilenko‐McGuigan C, Cans C, Gousset M, Pison C. Epidemiologie de l'allergie respiratoire de l'enfant. Arch Pediatr [Suppl] 1999; 6: 6–13.
    1. Mitchell EA. Asthma epidemiology: clues and puzzles. Pediatr Pulmonol [Suppl] 1999; 18: 31–33.
    1. Warner JO, Naspitz CK, Cropp GJA. Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998; 25: 1–17.
    1. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbation of asthma in adults. Br Med J [Clin Res] 1993; 307: 982–986.
    1. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. 1. Epidemiology. Clin Exp Allergy 1992; 22: 325–336.
    1. Johnston SL. Role of viral and atypical bacterial pathogens in asthma pathogenesis. Pediatr Pulmonol [Suppl] 1999; 18: 141–143.
    1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrell DAJ, Holgate S. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. Br Med J [Clin Res] 1995; 310: 1225–1229.
    1. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998; 11: 345–349.
    1. British Thoracic Society . Guidelines on the management of asthma. Thorax [Suppl] 1993; 48: 1–24.
    1. Andreolletti L, Lesay M, Deschildre A, Lambert V, Dewilde A, Wattre P. Differential detection of rhinoviruses RNA sequences associated with classical immunofluorescence assay detection of respiratory virus antigens in nasopharyngeal swabs from infants with bronchiolitis. J Med Virol 2000; 61: 341–346.
    1. Gama RE, Horsnell PR, Hughes PJ, North C, Bruce CB, Al‐Nakib W, Stanway G. Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction. J Med Virol 1989; 28: 73–77.
    1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, Cunningham A, Robinson BS, Myint SH, Ward ME, Tyrrel DA, Holgate ST. The relationship between upper respiratory infections with hospital admissions for asthma: a time trend analysis. Am J Respir Crit Care Med 1996; 154: 654–660.
    1. Johnston SL. Viral infections in children with existing asthma In: Chanez P, Bousquet J, Michel FB, Godard P, editors. From genetics to quality of life. The optimal treatment and management of asthma. Seattle: Hogrefe and Huber Publishers; 1996. p 102–107.
    1. Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, Gouarin S, Duhamel JF, Guillois B. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999; 13: 131–139.
    1. Freymuth F, Vabret A, Gallateau‐Salle F, Ferey J, Eugene G, Petitjean J, Gennetay E, Brouard J, Jorik M, Duhamel JF, Guillois B. Detection of respiratory syncytial virus, parainfluenzavirus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by PCR and hybridization. Clin Diagn Virol 1997; 8: 31–40.
    1. Johnston SL, Sanderson G, Pattemore PK, Smith S, Bardin PG, Bruce CB, Lambden PR, Tyrrel DA, Holgate ST. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with or without respiratory symptoms. J Clin Microbiol 1993; 31: 111–117.
    1. Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 1994; 16: 351–373.
    1. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, Blomqvist S, Hyypia T, Arstila P. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998; 36: 539–542.
    1. Dallo SF, Baseman JB. Intracellular DNA replication and long‐term survival of pathogenic mycoplasmas. Microb Pathog 2000; 29: 301–309.
    1. Gendrel D. Intracellular pathogens and asthma: Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric patients. Eur Respir Rev 1996; 38: 231–234.
    1. Hahn DL. Intracellular pathogens and their role in asthma: Chlamydia pneumoniae in adult patients. Eur Respir Rev 1996; 38: 224–230.
    1. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618–625.
    1. Hahn DL, Peeling RW, Dillon E, McDonald R, Saikku P. Serologic markers for Chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol 2000; 84: 227–233.
    1. Tomasi TB, Grey HM. Structure and function of immunoglobulin A. Prog Allergy 1972; 16: 181–213.
    1. Emre U, Roblin P, Gelling M, Dumornay W, Rao M, Hammerschlag MR, Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727–732.
    1. Clyde WA. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis [Suppl] 1993; 17: 32–36.
    1. Mygind N, Gwaltney JM, Winther B, Owen Hendley J. The common cold and asthma. Allergy [Suppl] 1999; 54: 146–159.
    1. Papadopoulos NG, Johnston SL. Rhinovirus as pathogens of lower respiratory tract. Can Respir J 2000; 7: 409–414.
    1. Gern JE, Calhoun W, Swenson C, Shen G, Busse WW. Rhinovirus infection preferentially increases lower responsiveness in allergic subjects. Am J Respir Crit Care Med 1997; 155: 1872–1876.
    1. Corne JM, Holgate ST. Mechanisms of virus induced exacerbations of asthma. Thorax 1997; 52: 380–389.
    1. Welliver RC. Immunologic mechanisms of virus‐induced wheezing and asthma. J Pediatr 1999; 135: 14–20.
    1. Erb KJ. Atopic disorders: a default pathway in the absence of infection? Immunol Today 1999; 20: 317–322.
    1. Hahn DL, Bukstein D, Luksin G, Zeitz H. Evidence for Chlamydia pneumoniae infection in steroid‐dependant asthma. Ann Allergy Asthma Immunol 1998; 80: 45–49.
    1. Black P. The use of macrolides in the treatment of asthma. Eur Respir Rev 1996; 38: 240–243.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera